Two Sigma Advisers’s Ascendis Pharma A/S ASND Stock Holding History

Two Sigma Advisers’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-47,400	Closed	-$10.1M	–	182
2025 Q4	$10.1M	Buy	47,400 +14,500	+44%	+$2.99M	0.02%	536
2025 Q3	$6.54M	Buy	+32,900	New	+$6.14M	0.01%	644
2025 Q1	–	Sell	-5,400	Closed	-$743K	–	2384
2024 Q4	$743K	Sell	5,400 -41,858	-89%	-$5.5M	﹤0.01%	1605
2024 Q3	$7.06M	Sell	47,258 -154,742	-77%	-$20.9M	0.02%	588
2024 Q2	$27.5M	Buy	202,000 +38,600	+24%	+$5.25M	0.06%	262
2024 Q1	$24.7M	Buy	+163,400	New	+$23.3M	0.06%	296

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Advisers's ASND Position: Q1 2026 in Review

Two Sigma Advisers sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 47,400 shares — an estimated $10.1M sold.

Two Sigma Advisers first reported a position in ASND in Q1 2024 and held it in 6 quarters. The position peaked at $27.5M in Q2 2024. 274 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Two Sigma Advisers reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 47,400 Ascendis Pharma A/S shares in Q1 2026, an estimated $10.1M.
Two Sigma Advisers first reported a position in Ascendis Pharma A/S in Q1 2024 and held it in 6 quarters.
Two Sigma Advisers's Ascendis Pharma A/S position peaked at $27.5M in Q2 2024.
274 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.